| URL | http://www.areadevelopment.com/newsItems/3-30-2018 |
| Source | Area Development |
| Date Published | 03/30/2018 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | AGC Biologics |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2018 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Bothell |
| State(s) reshored to: | WA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Therapeutic Proteins |
| What domestic positive factors made reshoring more attractive? | Customer responsiveness improvement, Proximity to customers/market |